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When exposed to glass, mammalian plasma acquires the ability to accelerate 
clotting,  increase  vascular  permeability,  induce  pain,  cause  contraction  of 
smooth muscle, and dilate blood vessels.  These properties are dependent upon 
the presence of Hageman factor, a plasma protein which circulates in inactive 
form until  "activated" by contact with glass  or a number of other insoluble, 
negatively charged  substances  (1).  Recently it  has  been demonstrated  that 
very dilute  solutions of ellagic  acid also can  activate  Hageman factor by a 
mechanism as yet unknown (2). The activated Hageman factor then activates 
plasma thromboplastin antecedent (PTA), thus initiating the series of reactions 
which lead to clotting (3). 
Hageman  factor,  activated  by  ellagic  acid,  has  been  shown  to  increase 
vascular permeability when injected into the skin of the guinea pig  (4).  Be- 
cause  the  relationship  of increased  vascular  permeability  (as  demonstrated 
by the extravasation of protein-bound dye) to the margination and emigration 
of leucocytes is still unclear, it seemed desirable to test the effects of activated 
Hageman factor in a system permitting the direct visualization of the micro- 
circulation.  In the present studies this has been done, utilizing  a modification 
of the Sandison-Clark rabbit ear chamber. It also seemed of interest to compare 
the inflammatory effects of Hageman factor with those of bradykinin, since the 
activation of Hageman factor has been shown to be associated with the ap- 
pearance of kinin-like  activity in plasma (5). 
Metkods and Materials 
Rabbit  Ear Chamber.--The  ear chamber used in these experiments has been described in 
detail in the previous communication (6). It is a further modification of the Sandison-Clark 
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chamber (7, 8). Two features of the present chamber are of special significance for the studies 
described in this paper. One is the incorporation of a valve for the atraumatic introduction of 
test materials, an innovation originally proposed  by Sanders  (9). The other is the greater 
thickness of the tissue over the chamber table (70 to 100 ~.) which protects the vessels from 
minimal mechanical trauma, while retaining acceptable optical characteristics. These modifi- 
cations prevent the non-specific inflammatory reactions which resulted from the introduction 
of materials into earlier chambers. Thus, for the first time, very early inflammatory phenomena 
of small magnitude can be related to the specific test substance and distinguished from non- 
specific effects of trauma. The present chamber has the further advantage that repeated injec- 
tions of test materials can be made into it, so that the responses to different stimuli can  be 
compared in the same blood vessels. 
A modified experimental procedure was used in the present series of experiments in order 
to permit detailed observation of the early, transient reactions produced by some of the test 
materials. At the beginning of each experiment, approximately 0.004 ml of test material was 
introduced through the valve into the chamber by means of a syringe microburet (6). Obser- 
vations were recorded at 2, 5,  10,  15, 20, 30, 45, 60, 90, and 120 minutes after injection. In 
many experiments, further observations were made after 120 minutes. Each observation was 
recorded in a  manner similar to that described in the preceding paper (6). Two preselected 
segments of venules were examined, and the number of leucocytes "rolling"  and "sticking" 
was recorded. A cell was considered to be rolling if it was seen moving slowly along the endo- 
thelium at a rate slower than that of the axial stream of the venule. A leucocyte was considered 
to be sticking if it was firmly adherent to the endothelial surface. It is generally supposed 
that rolling represents, to a lesser degree, the same phenomenon as sticking. Numbers of stick- 
ing or roiling cells greater than 100 were recorded as 100, because it was found that numbers 
of cells greater than this could not be counted accurately. The entire chamber was also ex- 
amined for rolling and sticking of leucocytes and for evidence of leucocytic emigration. The 
amount of emigration was estimated and scored on an arbitrary scale, the details of which 
have been described previously (6). In the experiments with Hageman factor the inflammatory 
index (I.L) was calculated (6) because it was found to provide a useful means of comparison 
of the effects of this substance with those of its controls. 
Measureraent o/Increased  Vascular Permeability.--Intradermal  injections of test materials 
were made in the shaved backs of rabbits as previously described (6). Pontamine sky blue 
(E. I. DuPont De Neumours and Co., Inc., Wilmington, Delaware) was given intravenously 
as described before, except that the dye was injected immediately before the intradermal in- 
jections, rather than 30 minutes afterward as in the previous experiments. Intradermal injec- 
tion sites were examined at 15, 30, 45, 60, 90, and 120 minutes after injection, and blue spots 
5 mm or more in diameter were considered positive. 
Saline.--Most substances were dissolved in pyrogen-free, sterile 0.15 M NaC1 solution be- 
fore use. The NaC1 solution, which will hereafter be referred to as "saline" also was employed 
as a control material in both the ear chamber and the skin. 
ttageman Factor.--Purified  Hageman factor was prepared from citrated human plasma by 
a  previously described method  (10).  The preparations used were purified 3000- to 5000-fold 
and contained 2 to 8 per cent protein; the non-protein solid was trisodium ethylenediamine 
tetra-acetic acid. The preparations were free of detectable amounts of other clotting factors, 
but were probably contaminated with traces of plasminogen. Originally, the preparations of 
Hageman factor were thought to be in  the activated state. Subsequent studies demonstrated 
that only 1 to 8 per cent of the Hageman/actor was in the activated form (2). In the experi- 
ments described herein, Hageman factor was dissolved in sterile barbital-saline buffer at pH 
7.5 in a concentration of 4 mg per ml (3). 
Ellagic A cid.--Ellagic  add (4,4', 5,5', 6,6'-hexahydroxydiphenie acid 2,6: 2', 6'-diiactone), 
an activator of Hageman factor, was dissolved in barbital-saline buffer at a concentration of GRAHAM~ EBERT~  RATNOFF~ AND  MOSES  809 
2  X  10  -4 M with the aid of a  mechanical homogenizer. Both crude, commercial ellagic acid 
(K and K Laboratories Inc., Plainview, New York) and synthetic ellagic acid, prepared in the 
laboratories of the Department of Chemistry, Western Reserve University, were tested; the 
effects of each were indistinguishable. To prepare activated Hageman factor, equal parts of 
solutions of Hageman factor and ellagic acid were mixed, giving final concentrations of 2 mg 
per ml for Hageman factor, and 10-  4 M for ellagic acid. 
TABLE I 
The Inflammatory  Effects of Activated Hageman Factor 
Ear chamber 
382 R 
382 R 
746 L 
700 L 
805 L 
762 L 
806 L 
746 R 
612 L 
Inflammatory index 
Hageman factor  E]lagic acid  Hageman  factor  plus  eliagic acid 
191 
14 
0 
5 
95 
0 
0 
0 
140 
10 
5 
0 
5 
0 
ACTIVATED  HAGEMAN  FACTOR 
14£1, 
616 
266 
505 
86 
440 
230 
750 
IC 
30  60  90  120 
MINUTES  AFTER INJECTION 
TExT-FIG.  1.  Graphic representation of a  typical reaction to activated Hageman factor. 
The stippled area beneath the solid line joined by triangles (score for the reaction) is the in- 
flammatory index. The cross-hatched, stippled area between the total score and the number 
of cells sticking represents the portion of the inflammatory index contributed by the exudate. 
The number of cells rolling is not a factor in the numerical evaluation of the reaction.  (See 
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Bradykinin.--Synthetic  bradykinin ("BRS 640" Lot 013 12) was kindly donated by Sandoz 
Pharmaceuticals, Incorporated,  Hanover, New Jersey. 
RESULTS 
Saline.--Before use  in  experiments  new  ear  chambers  were  "stabilized"  by 
repeated  injections  of  saline  (6).  Mter  stabilization  the  maximum  reaction  to 
saline  consisted  of  transient  arteriolar  dilatation  and  moderate  rolling  of 
TABLE  II 
The Response to Hageman Factor plus Ellagic Acid in the Rabbit Ear Chamber 
Ear 
cham- 
ber 
Before injection 
R*  S*  1~  A[ 
382R  0  N 
382R  0  D 
7~L  2  0  0  N 
805L  6  1  0  N 
762L  0  N 
806L  3  I  O[  0  C 
Minutes after injection 
10  30  60  90  120 
R  S  E  A  P.  S  E  A  S  !  E  R  SE  A 
7  0  D 
6  0  D 
17  1  0  C 
8  0  O  N 
11  2  0  D 
7  4  0  D 
2  2  0  N 
69  0 
5  0 
12  2  0 
22  8  0 
10  2  0 
55  6  0 
6  460 
N  93  + 
D  25i  0 
N  18  t5  0 
N  {]  25  0 
D!?  2  0 
D  18  6  0 
D  5  90  + 
R 
N 
D 
D  25 
N 
D  10 
n  28 
D  8 
too  ++ 
6  0 
34  + 
]00  ++ 
A  R 
D  50 
15 
D  8 
D  7 
D  35 
S  E  A 
91  +  N 
:tO0  +  D 
too  +++  D 
i  15  0  N 
[ 30  0  D 
100  +  D 
]70  +++  D 
* Mean number of cells rolling in arbitrary venular segments. 
Mean number of  cells sticking in arbitrary venular segments. 
§ Amount of emigration (arbitrary scale of 0 to ++++). 
]1 Arteriolar tone (N, normal, D, dilated, C, constricted). 
140 
12O 
Q: 
~  80 
k 
GRANULOCYTIC  SUBSTANCE 
--  o-~-0  Mean number  of cells  rolling 
----  :  Meonnumborofcellssticking  ~~ 
~,  A  Arbitrary  score for reaction 
30  60  90  t 20 
MINUTES AFTER INJECTION 
TExT-Fro.  2.  Graphic representation of a  typical reaction to granulocytic substance.  See 
explanation for Text-fig.  I. GRAHAM~ EBERT,  RATNOFI~  AND  MOSES  811 
leucocytes. In many stable chambers saline injection was followed by no de- 
tectable  reaction.  Significant  sticking  and  emigration  of leucocytes did  not 
result from saline injection in stable chambers. In a few chambers non-specific 
reactions of significant proportions continued to occur; these chambers were 
not used for study of test materials. 
Delayed reactions, such as those reported following injection of saline and 
BRADYKININ 
60 
(:~ ~  0---'-0  Mean  number  of cells rolling 
~.. ~  ,10  -  :  Mean number of cells sticking 
'~:  20 
0  f  1 
30  60  90  120 
MINUTES  AFTER  IN,/ECT/ON 
TEx¢-FIo. 3.  Graphic representation of a reaction to bradykinin (5/zg/rnl) in the rabbit 
ear dlamber. 
I  BRADYKININ 
IOOi 
8o 
60  --  :  Mean number of cells sticking 
30  60  90  120 
MINUTES  AFTER INJECTION 
T~xT-Fzo. 4.  Graphic representation of a reaction to bradykinin in the ear chamber. The 
same dose as in Text-fig. 3 was given to a different chamber illustrating the variability of re- 
sponse among chambers. 
other  substances  by  Hurley  and  Spector  (11)  were  not  observed in  stable 
chambers during 3 hours of observation. 
Inactive Hageman Factor.--In six  of  eight  experiments inactive Hageman 
factor produced no more reaction than saline. Transient rolling of leucocytes 
occurred shortly after injection, but no significant fixed sticking occurred and 
no emigration of leucocytes was seen. In two experiments a somewhat greater 
reaction  was  observed  (Table I)  and  there  was  m]niroal  to  moderate fixed 
sticking between 30 to 90 minutes after injection. No emigration of leucocytes 
occurred, however. 812  PATttOGElqESIS  OF  INFI~M'MATION.  II 
Ellagic Acid.--In  five of six  experiments  10  -4 M ellagic  acid  produced  no 
more reaction than did the control injection of saline (Fig.  1 a). In one experi- 
ment fixed sticking occurred between 30 and 90 minutes but this was minimal 
and no emigration of leucocytes occurred. 
ttageman  Factor  Plus  Etlagic  Acid.--Purified  Hageman  factor,  activated 
by 10-~ ellagic acid, consistently evoked an inflammatory response which was 
delayed in onset and relatively prolonged  (Text-fig.  1).  Rolling of leucocytes 
often  was  increased  at  10  minutes  and  usually  reached  its  peak  about  30 
minutes  after  injection.  By this  time  fixed sticking  of leucocytes was often 
apparent.  Sticking then gradually increased, usually becoming marked 45 to 60 
minutes after injection  (Fig.  1  b).  The reaction generally reached its peak 90 
R~ 
Cunc. 
I.~g per 
ml 
5 
5 
5 
10 
10 
TABLE III 
~resentative Experiments Illustrating the Effect of Bradykinin in the Rabbit Ear Chamber 
Ear 
cham- 
ber 
746R 
746L 
612L 
762L 
805L 
Before injection 
R*  S$  E§  AIt 
3  0  0IN 
2  0  0iN 
5  1  0IN 
10  1  0  N 
1  1  0  N 
10 
R  SE[A 
1 
i 
75  1 0  D 
50  5  0  D 
23  53  0  n 
85  16  C  D 
7  32  0  D[ 
Minutes after injection 
30 
R  SE  A 
53  0  0  N 
18  11  0  N 
9  73+  N 
3,5  41  0  N 
7  9  0  N 
R  SE  A 
5  0  0  N 
5  6ON 
6  52  0  D 
8  0  0  N 
24  0  N 
90 
R  S  E  A 
6  0  0  D 
7 113  0  N 
43  8 +-f  D 
14  1  0  N 
15  4[  0  D  I 
120 
2  C  0 
7 IC  0 
2s 2c ++ 
54  £  0 
7  9  0 
N 
D 
D 
N 
D 
* Mean number of cells rolling  in arbitrary venular  segments. 
Mean number of cells sticking in arbitrary venular segments. 
§ Amount of emigration  (arbitrary scale of 0  to ++++). 
U  Arteriolar  tone  (hi, normal;  D, dilated;  C,  constricted). 
to 120 minutes after injection.  Significant emigration of leucocytes occurred in 
five of seven experiments  (Table LI).  Arteriolar  dilatation  and  rapid  venous 
flow were also delayed in onset,  occurring concomitantly  with  the leucocytic 
sticking and emigration. The inflammatory index in experiments with activated 
Hageman factor ranged from 86 to 750 with a mean of 413. This compared with 
a  mean inflammatory  index of 38 for inactive Hageman factor and of 27 for 
ellagic acid alone (Table I). 
The pattern of response to activated Hageman factor (Text-fig. 1) was quite 
similar to that observed after the injection of "granulocytic substance" (Text- 
fig. 2) previously described from this laboratory. It should be noted that both 
are  delayed  reactions,  usually  reached  their  peaks  about  90  minutes  after 
injection. 
Bradykinin.--The response of the microcirculation in the rabbit ear chamber 
to the injection of bradykinin (Text-figs. 3 and 4) was quite different from that GRAHAM, EBERT, RATNOFF, AND MOSES  813 
seen after the injection of activated Hageman factor (Text-fig. 1). Arteriolar 
dilatation appeared within a few seconds of the beginning of the injection but 
rarely persisted for more than 15 minutes. Soon after the onset of arteriolar 
dilatation, many leucocytes were seen rolling slowly along venular endothelium. 
This phenomenon usually was most prominent 2 to 5 m;nutes after injection. 
In the larger reactions many of the leucocytes began to adhere firmly to the 
endothelium within a few minutes of the onset of rolling. This sticking ordinarily 
reached its peak 10 to 20 minutes after injection, subsiding gradually thereafter 
(Fig. 2 a  to 2 d). In the more intense reactions emigration of leucocytes was 
sometimes observed, usually apparent 20 to 30 minutes after injection (Fig. 3). 
14 
I0 
8 
6 
o----o  Brodykinin 
X~x  Hagemon  Factor  +  Ellagic  Acid 
Ellagic  Acid 
o---.  Hageman  Factor 
/ 
/ 
/ 
/ 
/ 
/ 
_'z'  "_ 
I  I  1 
0  30 
-.-o 
X  'X 
u  ~  m 
I  I  I  I  I  I 
60  90  120 
MINUTES  AFTER  INJECTION 
TEXT-FIG. 5.  Comparison of permeability effects of bradykinin with Hageman factor and 
ellagic acid alone and Hageman factor activated  by ellagic acid. Note the delay in onset of 
enhanced permeability with activated Hageman factor. 
Different ear chambers varied markedly in reactivity (Table HI), but each 
reacted consistently to a given dose of bradyk;n;no Several chambers exhibited 
significant leucocytic sticking after as little as  2 #g per ml,  and detectable 
emigration after 4 to 5 #g per ml. On the other hand, an occasional chamber 
could be injected with as much as 40 or even 80 #g per ml with only moderate 
sticking and no significant emigration resulting. These differences were thought 
to depend largely on variable patterns of blood flow in individual chambers. In 
spite of the variability in magnitude, the pattern of reaction was quite char- 
acteristic. In all, thirty experiments were performed in ten different chambers, 814  PATHOGENESIS OF INFLA~TION.  II 
using  concentrations  of  bradykinin  ranging  from 0.25  to  80  ~g  per  ml.  In 
twenty-four experiments in which the concentration of bradykinin was  4 ~g 
per ml or greater, detectable emigration occurred in five. Emigration was not 
observed after concentrations of bradykinin lower than 4 #g per ml. 
A  Comparison of the Abilities of Bradykinin and Activated Hageman Factor to 
Increase  Vascular  Permeability  in Rabbit Skin.--Bradykilfin  in concentrations 
as low as 0.0002/~g per ml increased vascular permeability in the skin of rabbits 
injected intravenously with pontamine sky blue. Bluing of the test area was 
evident within 5 to 10 minutes after intradermal injection of bradykinin, and 
intense bluing was noted after 30 minutes. In contrast a mixture of Hageman 
factor and ellagic acid caused a  delayed increase in vascular permeability in 
rabbit skin (Text-fig. 5). No blue staining was usually evident until about 60 
minutes after intradermal injection and became more intense after 90 to 120 
minutes. 
DISCUSSION 
It has been demonstrated that activated Hageman factor causes significant 
and prolonged sticking of leucocytes to the endothelium of small blood vessels 
in rabbit ear chambers and that, subsequently, emigration of leucocytes can 
occur. Hageman factor in its inactive form (in terms of clot-promoting potency) 
has insignificant inflammatory effects. 
Activated Hageman factor is thought to liberate a plasma k~nln by initiating 
the series of reactions outlined in Text-fig. 6.  The activated Hageman factor 
HAGEMAN  FACTOR 
GLASS,  ETC. 
KININOGEN 
ELLAGIC  ACID 
ACTIVATED 
HAGEMANFACTOR 
PLASMA 
KALLIKREINOGEN  ~-  KALLI KREIN 
PLASMA 
KININ 
TExT-Fro. 6. Postulated role of activated Hageman factor in the liberation of plasma 
kinin by activation of the plasma kallikrein system. GRAHAM, EBERT,  RATNOY1  ~,  AND  MOSES  815 
apparently acts upon a plasma protein called kallikreinogen to liberate plasma 
kallikrein, a proteolytic enzyme. The kallikrein then catalyzes the release of a 
plasma kinin from kininogen,  a circulating alpha-2  globulin.  While the exact 
nature of this kinin has not been determined, it is probably bradykinin or a 
closely related polypeptide (1, 5). 
The role of Hageman factor in naturally occurring inflammation is obscure. 
However, there is some evidence for the participation of kinin.q in the patho- 
genesis  of  certain  inflammatory reactions.  Rochg~e  Silva  (12)  obtained  a 
kinin-like substance from rat paws scalded at 45-48°C.  FAery and Lewis (13) 
collected lymph from the hind limbs of dogs subjected to injury. They found 
increased kinin-forming activity, but no detectable preformed klniu.  A recent 
study by Goldfinger and associates  (14) provides evidence that kinins may be 
involved in the pathogenesis of several types of synovial inflammation. These 
workers recovered a kinin-like  material from inflamed joints of patients with 
gout, rheumatoid arthritis, and psoriatic arthritis. When urate crystals were 
injected into the knees of a  gouty volunteer, a  50-fold increase in kinin-like 
activity accompanied a  striking  inflammatory response.  This  latter  finding 
is of particular interest since Kellermeyer and Breckenridge (15) have demon- 
strated that urate crystals can activate Hageman factor in vitro. 
It is  not known whether the inflammatory effects of activated Hageman 
factor are the result of kinin release, or whether they depend upon some other, 
presently unknown mechanism. If the delayed inflammatory reactions caused 
by activated Hageman factor are indeed finally mediated by the liberation of 
kinin, the present findings would seem to be of considerable theoretical interest. 
As the present studies indicate, the immediate and rather transient inflamma- 
tory response  evoked by preformed bradykinin is  quite dissimilar  from the 
reaction elicited by activated Hageman factor, which is delayed, prolonged, 
and characterized by prominent sticking and emigration of leucocytes. It seems 
possible, then, that prolonged endogenous release of kinins may produce effects 
quite different from those observed after the usual single injection of exogenous 
kinin. If this is correct, kinins deserve further investigation as possible partici- 
pants in the pathogenesis of the delayed phase of inflammation. 
Another problem  complicates the  interpretation  of  the  Hageman  factor 
experiments. Although activated Hageman factor produces a delayed response 
both in the rabbit ear chamber and in rabbit skin, it results in early and tran- 
sient bluing in the skin of the guinea pig (4,  16). It is not known whether 
Hageman factor evokes  emigration of leucocytes in  this  animal.  This  dis- 
crepancy recalls the species difference noted by Wilhelm and associates  (17) in 
studying globulin permeability factors. In the rabbit, homologous permeability 
factor evoked a delayed and prolonged increase in permeability. In contrast, 
homologous permeability factors produced immediate, transient responses  in 
the rat and guinea pig. Curiously, rabbit permeability factor evoked immediate 816  PATHOGENESIS  O]~  INFLAMMATION.  II 
transient responses in rats and guinea pigs, and permeability factors from the 
latter  two species  resulted in immediate, transient permeability increases in 
the rabbit. The reasons for these species differences are totally unknown, and 
the two examples are perhaps not comparable since the Hageman factor used 
in the current experiments was not homologous. Nevertheless, generalization 
between species is clearly hazardous on the basis of the present information. 
The similarities of the reactions evoked by activated Hageman factor and 
granulocytic substance (6)  raised the question of the possible identity of the 
two  substances.  In  preliminary  experiments,  granulocytic  substance  was 
tested for clot-promoting activity and, specifically, for ability to activate PTA. 
Clot-promoting activity could not be demonstrated because of the presence of 
an anticoagulant material in granuloc)~tic  substance. The mechanism of this 
anticoagulant activity is  currently being studied. Although Hageman factor 
and granulocytic substance are clearly not the same, it remains possible that 
they act in a similar fashion by liberating a common mediator. 
SUM'MARY 
Activated Hageman factor, when injected into the rabbit ear chamber, pro- 
duces a delayed and prolonged inflammatory response characterized by promi- 
nent sticking and emigration of leucocytes. In contrast, preformed bradykinin 
evokes an immediate and more  transient response  in which leucocytic emi- 
gration  occurs  less  frequently. It  is  concluded that  either  Hageman factor 
produces its inflammatory effects by mechanisms other than kinin release, or 
bradykinin released endogenously has effects quite different from those resulting 
from a single injection of the exogenous material. 
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EXPLANATION OF PLATES 
PLATE 60 
FIG. 1 a.  Forty-five minutes after injection of eUagic acid alone. Only a few roiling 
leucocytes are evident. ×  700. 
FIc. 1 b.  Forty-five minutes after injection of a  mixture of Hageman factor and 
eUagic acid. There is extensive sticking of leucocytes to venular endothelium. ×  700. THE  JOURNAL  OF  EXPERIMENTAL MEDICINE  VOL. 121  PLATE 60 
(Graham eta/.: Pathogenesis of inflammation. II) PLATE 61 
FIGS. 2 a to2 d. Sequential changes of arteriole (A) and venules of rabbit car chamber 
before and after injection of bradykinin 5 #g per ml.  ×  200. 
FIG. 2 a.  Before injection. Appearance of vessels is normal 
FIG. 2 b.  Three minutes after bradykinin. Arteriole (A)  is widely dilated, venular 
flow is rapid, and many rolling leucocytes are apparent. 
FIG. 2 c.  Twelve minutes after  bradykinin. Marked  arteriolar dilatation persists. 
Leucocytes can be seen sticking to venular endothelium. 
FIG. 2 d.  Seventeen minutes after bradykinin. Arteriole (A) is only slightly dilated. 
Only a few leucocytes are still sticking. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  61 
(Graham et al.: Pathogenesis of inflammation. II) PLATE 62 
FIG. 3  Extensive sticking of leucocytes to  venular endothelium 20  minutes after 
injection of bradykinin (5 ~g per ml.). Even when the response to a single injection of 
bradykinin was this marked, it was quite transient, largely subsiding within an hour. 
X  680. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  121  PLATE  62 
(Graham et al. : Pathogenesis of inflammation. II) 